Share

The next edition of Journal Club will be on March 1st, 2018 at 13:00 EST/18:00 UK live on our Facebook page.

And yes, we know it’s the February edition of the club and it’s airing in March, but we could not broadcast sooner due to things happening at Cooper Union beyond our control; we will do the next club a bit earlier to keep it in the right month and avoid confusion.

Anyway, the topic for the show will be a new publication by Dr. Maria Blasco demonstrating the reversal of pulmonary fibrosis in an excellent new mouse model of the disease. This is an important step forward for the potential treatment of fibrosis, as currently there are no effective cures for this disease.

Reference

Povedano, J. M., Martinez, P., Serrano, R., Tejera, Á., Gómez-López, G., Bobadilla, M., … & Blasco, M. A. (2018). Therapeutic effects of telomerase in mice with pulmonary fibrosis induced by damage to the lungs and short telomeres. eLife7, e31299.

About the author

Oliver Medvedik

Oliver Medvedik, Co-founder of Genspace citizen science laboratory in Brooklyn NY, earned his Ph.D. at Harvard Medical School in the Biomedical and Biological Sciences program. As part of his doctoral work he has used single-celled budding yeast as a model system to map the genetic pathways that underlie the processes of aging in more complex organisms, such as humans. Prior to arriving in Boston for his doctoral studies, he has lived most of his life in New York City. He obtained his bachelor’s degree in biology from Hunter College, City University of New York. Since graduating from Harvard, he has worked as a biotechnology consultant, taught molecular biology to numerous undergraduates at Harvard University and mentored two of Harvard’s teams for the international genetically engineered machines competition (IGEM) held annually at M.I.T.
Write a comment:

*

Your email address will not be published.

12 + twenty =

© 2018 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD